| 000 | 01473 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512101908.0 | ||
| 264 | 0 | _c19711030 | |
| 008 | 197110s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, D H | |
| 245 | 0 | 0 |
_aMechanism of antilipolytic effects of cardiac glycosides. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cApr 1971 |
||
| 300 |
_a284-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdipose Tissue _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aButyrates _xpharmacology |
| 650 | 0 | 4 |
_aCardiac Glycosides _xpharmacology |
| 650 | 0 | 4 |
_aCell Membrane _xdrug effects |
| 650 | 0 | 4 |
_aCyclic AMP _xpharmacology |
| 650 | 0 | 4 |
_aDigitoxin _xpharmacology |
| 650 | 0 | 4 |
_aEpididymis _xdrug effects |
| 650 | 0 | 4 | _aEsters |
| 650 | 0 | 4 |
_aGlycerol _xmetabolism |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 |
_aOuabain _xpharmacology |
| 650 | 0 | 4 |
_aPhosphoric Monoester Hydrolases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPotassium _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aStrophanthins _xpharmacology |
| 650 | 0 | 4 |
_aTheophylline _xpharmacology |
| 650 | 0 | 4 | _aTritium |
| 700 | 1 | _aTriester, S | |
| 700 | 1 | _aGluckman, M I | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 177 _gno. 1 _gp. 284-90 |
|
| 999 |
_c4332710 _d4332710 |
||